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Introduction: Short leukocyte telomere length (LTL) is associated with
atherosclerosis in adults and diminished survival in the elderly. The prevailing
view is that LTL is associated with accelerated aging since it serves as a bio-
marker of the cumulative burden of inflammation and oxidative stress during
adult life. LTL dynamics are defined by LTL at birth, which is highly vari-
able, and its age-dependent attrition thereafter, which is rapid during the first
20 years of life. We examined whether age-dependent LTL attrition during old
age can substantially affect individuals’ LTL ranking (e.g., longer or shorter
LTL) in relation to their peers and which clinical, lifestyle or genetic factors
can predict it.
Methods: We measured LTL by Telomeric Restriction Fragment Southern
Blot (TRF) in samples donated 8 years apart on average by 76 participants of
the ADELAHYDE study. Participants were men and women aged 60 to
85 years with a history of hypertension at the inclusion.
Results: We observed a mean LTL attrition of 27 bp per year which is
consistent with previous data on telomere attrition in adults. No clinical, life-
style or genetic factors seem to exert significant effect or can predict LTL
attrition in elderly people. We observed a close relationship (r=0.88, figure left
panel) between baseline and follow-up LTL values. Ranking individuals by
quintiles revealed that 98.6 % showed no rank change (59.7%) or one quintile
change (38.9%) over time (figure right panel).
Conclusions: We conclude that in elderly people, LTL is virtually
anchored to a given rank with the passage of time. Accordingly, the links of
LTL with atherosclerosis and longevity appear to be established early in life.
It is therefore unlikely that lifestyle and its modification during old age exert
a major impact on LTL ranking.
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Mitochondrial dysfunction contributes to the pathogenesis of a wide
variety of common diseases, including cardiovascular diseases. Mitochon-
dria-triggered cell death is a major cause of cardiac injury following isch-
emia reperfusion (I/R). Aging is a physiological evolution of organisms and
the concept that mitochondrial function declines during aging has been
largely described for many years. Furthermore, aging is a major risk factor
for myocardial infarction. Sirtuin 3 (SIRT3) is a member of Sirtuin family
which is a NAD+ dependent deacetylase, preferentially localized into mito-
chondria. SIRT3 deacetylates some of the regulatory components of the
mitochondrial permeability transition pore (mPTP), cyclophilin D (CypD)
and complexes of the electron transport chain, both known to be involved in
cardioprotection. The goal of this study was to clarify the role of SIRT3 in
cardioprotection following aging, and its mechanism of action through mito-
chondrial functions.
To do so, we used WT and Sirt3 KO mice (129S6/SvEvTac) at different
ages: 2, 6 and 12 months. Mice underwent in vivo acute myocardial ischemia-
reperfusion at different ages. The infarct size was quantified and compared
between the different ages. Total mitochondrial acetylation, and acetylation
level of CypD and Complex I were quantified and in parallel we assessed
mPTP sensitivity to Ca2+ using Calcium Retention Capacity and Oxidative
Phosphorylation.
Our results show that the absence of SIRT3 prevents the beneficial effect
of cardioprotection by ischemic post-conditioning. SIRT3 KO mostly changes
the acetylation status of CypD and Complex I, and also increases by almost
30% mPTP sensitivity to Ca2+. We also demonstrate that aging changes
SIRT3 activity, which increases protein acetylation and decreases mPTP sen-
sitivity to Ca2+. 
Globally, this study enlightens the importance of SIRT3 activity as a
therapeutic target in cardioprotection.
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